1. Market Research
  2. > Agriculture
  3. > Livestock Market Trends
Bovine Respiratory Disease Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Bovine Respiratory Disease Treatment Industry: Forecasts to 2024

  • October 2016
  • 165 pages
  • ID: 4415250
In this report:
However, the veterinary clinics and veterinary research institutes segments are expected to grow steadily as majority of procedures are carried out in veterinary hospitals.
Moreover, according to the World Bank Group (2016), global human population is estimated to be ##.## billion in 2016 and is growing at a rate of ##.##% per year.

Summary

Table of Contents

Global Bovine Respiratory Disease Treatment Market: Summary

Bovine respiratory disease is a multifactorial and complex disorder caused due to combination of more than one microbial pathogens, impaired host immunity, inadequate housing conditions, and environmental factors. The main factor leading to bovine respiratory diseases are host factors, environmental factors, and direct influence of infectious agents including virus, bacteria, and parasites. On the other hand, due to growing consumption of milk and beef products, the need for bovine respiratory disease treatment has increased across the world.

Also, according to the World Bank Group (2016), overall human population is projected to be 7.4 billion in 2016 and is increasing at a rate of 1.80 percent per year. Hence, demand for beef has increased due to growing population and rising disposable income across the globe. The increasing demand for high quality bovine derived products is influencing the bovine respiratory disease treatment market. Despite of innovations in veterinary medicines and advancement in technology, bovine respiratory disease is the leading cause to impact negatively on both the dairy and beef industries due to calf mortality, additional labor cost and treatment expenses. Furthermore, bovine respiratory disease affects adversely on reproductive performance, increase and longevity of cattle. Hence, prevention and treatment of bovine respiratory disease have become decisive to decrease the impact on animal production and the beef industry. Therefore, the bovine respiratory disease treatment market is anticipated to witness serious growth in terms of income during the outlook period.

Global Bovine Respiratory Disease Treatment Market: Segmentation

In terms of treatment type, the bovine respiratory disease treatment market has been classified into vaccines, antibiotics, NSAIDs, and immunomodulators. Causative agents including viruses leading to bovine respiratory disease have no direct treatment. Hence, vaccination is the preferred choice of preventive action against the disease. This increase market potential for vaccines. Nevertheless, virus infected cattle is exposed to bacteria, parasites, and different other factors. Therefore, antibiotics are the preferred choice of treatment for bovine respiratory diseases. Effective treatment and meaningful demand has increased the scope for antibiotics in the bovine respiratory disease treatment market.

On the other hand, according to NCBI report, combination treatment with anti-inflammatory drugs including NSAIDs has superior results over the monotherapy of antibiotics. This has led to increase in usage of NSAIDs in bovine respiratory disease treatment. Bovine respiratory disease is generally treated with different combination therapies. Nevertheless, increasing resistance to antibiotics and drying pipeline has increased demand for novel treatment options for which cattle do not develop resistance, and consequently there is no impact on human life.

Development of newer generation antibiotics for cattle is anticipated to drive the overall bovine respiratory disease treatment market during the estimate period. In order to avoid the issue of antibiotics resistance in bovine population, preventive measures including vaccination and immunomodulators has observed increased overall acceptance against the bovine respiratory disease. Hence, preventive treatment is gaining momentum due to increasing awareness about the negative impact of antibiotics on human health. This has driven the sector for immunomodulators, vitamin injections, and other immunity building products.

In terms of disease type, the industry has been split into upper respiratory tract infections, diphtheria, and pneumonia. Upper respiratory tract infections dominated the overall bovine respiratory disease market, accounting for serious share in terms of income in 2015. Respiratory infections first affect the upper respiratory tract, which is also the most vulnerable region, succeeded by other parts of the respiratory tract. Diphtheria accounted for meaningful share of the bovine respiratory disease treatment market in 2015. Pneumonia accounted for high market share, followed after upper respiratory tract infection in 2015. Hence, early detection of infection is crucial in bovine respiratory diseases treatment.

In terms of distribution channel, the overall bovine respiratory disease treatment market has been divided into veterinary hospitals, veterinary clinics, private veterinary pharmacies, and veterinary research institutes. Veterinary hospitals dominated the overall bovine respiratory disease market in 2015. The segment dominated the market due to factors including growing population of cattle which increases prevalence of bovine respiratory diseases. The private veterinary pharmacies distribution channel segment is forecasted to register serious Compound annual growth rate during the outlook period. The segment is likely to witness strong growth in most of the emerging parts of the world and preference for medicines from private veterinary pharmacies for bovine serum respiratory diseases. On the other hand, the veterinary clinics and veterinary research institutes segments are anticipated to grow steadily as majority of procedures are carried out in veterinary hospitals.

Global Bovine Respiratory Disease Treatment Market: Geographical and Competitive Dynamics

Geographically, the bovine respiratory disease treatment market has been categorized in five main regions: North America (NA), Europe (EU), Latin America area, Asia-Pac, and Middle East area & African continent. North America continent held the main share of the overall bovine respiratory disease treatment market in 2015, where the U.S.A dominates the sector in terms of income. EU accounted for a meaningful share of the market in 2015. Changing environmental factors, increasing prevalence of causative agents for respiratory disease, growing demand for quality bovine products, and increasing bovine population are the top factors driving the bovine respiratory disease treatment market in Europe (EU). Asia Pacific (APAC) is the most important producer of bovine livestock. Hence, it presents serious opportunities in the bovine respiratory disease treatment market. India (IN) and China (CN) are the main markets for bovine respiratory disease treatment, as these have biggest livestock population compared to other countries across the world. Latin America area and Middle East (ME) & African continent have comparatively smaller markets for bovine respiratory disease treatment. Nevertheless, Brazil (BR), Mexico (MX), and Argentina are the emerging markets in Latin America due to meaningful number of livestock population.

Top players operating in the overall bovine respiratory disease treatment market are Merck & Co., Incorporated, Zoetis Services LLC, Bayer AG, Elanco, Merial, Boehringer Ingelheim GmbH, Virbac Group, Ceva, Vetoquinol, and Bimeda Animal Health, among others.

The bovine respiratory disease treatment segment has been split as follows:

Overall Bovine Respiratory Disease Treatment Market, by Treatment Type

Overall Bovine Respiratory Disease Treatment Market, by Disease Type

Overall Bovine Respiratory Disease Treatment Market, by Distribution Channel

Overall Bovine Respiratory Disease Treatment Market, by Geography

North America (NA)

USA

Canada (CA)

Europe (EU)

Germany (DE)

United Kingdom (UK)

France (FR)

Spain (ES)

Italy (IT)

Rest of europe (EU)

Asia-Pac

China (CN)

Japan (JP)

India (IN)

Australia & New Zealand

Rest of Asia-Pac

African region & Middle East

Saudi arabia (SA)

Untied arab emirates (uae)

South africa (SA)

North Africa (NA)

Rest of middle east and African regions (MEA)

Latin America

Brazil (BR)

Mexico (MX)

Rest of Latin America

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
Global Animal Medication Industry

Global Animal Medication Industry

  • $ 5600
  • September 2018

This report analyzes the worldwide markets for Animal Medication in US$ Million by the following End-Use Segments: Companion Animals, and Farm Animals.The Global market is further analyzed by the following ...

Grass-fed Beef Sector: Worldwide Forecast until 2022

Grass-fed Beef Sector: Worldwide Forecast until 2022

  • $ 2500
  • September 2018

About Grass-Fed BeefGrass-finished beef comes from cattle raise on a forage diet. While most cattle spend most of their lives in pastures, eating grass before moving to a feedlot for grain finishing, grass-fed ...

Global Veterinary Vaccines Industry

Global Veterinary Vaccines Industry

  • $ 5600
  • September 2018

This report analyzes the worldwide markets for Veterinary Vaccines in US$ by the following Product Segments: Companion Animal Vaccines (Canine Vaccines, & Feline Vaccines), and Livestock Vaccines (Porcine ...

Beef Market Trends in China $ 3000 August 2018


ref:plp2016

Reportlinker.com © Copyright 2018. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on